Echocardiographic and electrocardiographic presentations of patients with endomyocardial biopsy-proven cardiac amyloidosis
- Author:
Aslannif Roslan
1
Author Information
- Collective Name:Aslannif Roslan, MRCP; Suraya Hani Kamsani, MRCP; Nay Thu Win MRCP; Kin Leong Tan MRCP; Najmi Hakim, CTS; Ai Ming Tan, CTS; Wan Nabeelah Megat Samsudin, MD; Ahmad Tantawi Jauhari Aktifanus, MD; Malini Kerisnan, MD; Dalleen Leong, MD; Thamarai Supramaniam, MD; Lay Koon Tan, FACC; Amin Ariff, FACC
- Publication Type:Journal Article
- Keywords: Cardiac Amyloidosis; Left Ventricular Hypertrophy; Right Ventricular involvement; Myocardial Strain; Apical Sparing; Transesophageal echocardiogram
- From: The Medical Journal of Malaysia 2018;73(6):388-392
- CountryMalaysia
- Language:English
- Abstract: Objective: Cardiac amyloidosis is under diagnosed and its prevalence is unknown. This is a retrospective, nonrandomised, single centre study of patients with endomyocardial biopsy-proven cardiac amyloidosis focusing on their echocardiographic and electrocardiogram (ECG) presentations. This is the first case series in Malaysia on this subject. Methods: We identified all of our endomyocardial biopsyproven cardiac amyloidosis patients from January 2010 to January 2018 and reviewed their medical records. All patients echocardiographic and ECG findings reviewed and analysed comparing to basic mean population value. Results: In total there are 13 biopsy-proven cardiac amyloidosis patients. All of the biopsies shows light chain (AL) amyloid. Majority of the patients (8, 61.5%) is male, and most of our patients (8, 61.5%) is Chinese. All seven patients on whom we performed deformation imaging have apical sparing pattern on longitudinal strain echocardiogram. Mean ejection fraction is 49.3%, (SD=7.9). All patients have concentric left ventricular hypertrophy and right ventricular hypertrophy. Diastolic dysfunction was present in all of our patients with nine out of 13 patients (69.2%) having restrictive filling patterns (E/A ≥2.0 E/e' ≥15). On electrocardiogram, 12 (92%) patients have prolonged PR interval (median 200ms, IQR 76.50ms) and 9 (69.2%) patients have pseudoinfarct pattern. Conclusion: Echocardiography plays an important role in diagnosing cardiac amyloidosis. The findings of concentric left ventricular hypertrophy with preserved ejection fraction without increased in loading condition should alert the clinician towards its possibility. This is further supported by right ventricular hypertrophy and particularly longitudinal strain imaging showing apical sparing pattern.
- Full text:6.2018my1353.pdf
